mTOR 与癌症：一条通路上的多个环。
mTOR and cancer: many loops in one pathway.
机构信息
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, United States.
出版信息
Curr Opin Cell Biol. 2010 Apr;22(2):169-76. doi: 10.1016/j.ceb.2009.10.007. Epub 2009 Nov 27.
Abstract
The mammalian target of rapamycin (mTOR) is a master regulator of cell growth and division that responds to a variety of stimuli, including nutrient, energy, and growth factors. In the last years, a significant number of pieces have been added to the puzzle of how mTOR coordinates and executes its functions. Extensive research on mTOR has also uncovered a complex network of regulatory loops that impact the therapeutic approaches aimed at targeting mTOR.
摘要
哺乳动物雷帕霉素靶蛋白（mTOR）是细胞生长和分裂的主要调节因子，对各种刺激（包括营养、能量和生长因子）作出反应。在过去几年中，人们对 mTOR 如何协调和执行其功能有了更多的了解。对 mTOR 的广泛研究还揭示了一个复杂的调节环网络，这些调节环网络影响着靶向 mTOR 的治疗方法。
相似文献
1
mTOR and cancer: many loops in one pathway.mTOR 与癌症：一条通路上的多个环。
Curr Opin Cell Biol. 2010 Apr;22(2):169-76. doi: 10.1016/j.ceb.2009.10.007. Epub 2009 Nov 27.
2
Dissecting the role of mTOR: lessons from mTOR inhibitors.剖析mTOR的作用：来自mTOR抑制剂的经验教训。
Biochim Biophys Acta. 2010 Mar;1804(3):433-9. doi: 10.1016/j.bbapap.2009.12.001. Epub 2009 Dec 11.
3
New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.哺乳动物雷帕霉素靶蛋白信号通路抑制剂在癌症治疗中的应用
Expert Opin Investig Drugs. 2010 Aug;19(8):919-30. doi: 10.1517/13543784.2010.499121.
4
Functional consequences of mTOR inhibition.mTOR抑制的功能后果。
Curr Opin Drug Discov Devel. 2010 Jan;13(1):31-40.
5
Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells.Mnk2-eIF4E反馈环在mTORC1靶向人髓母细胞瘤细胞过程中的调节作用
Oncotarget. 2014 Sep 30;5(18):8442-51. doi: 10.18632/oncotarget.2319.
6
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.LKB1 和 AMP 激活的蛋白激酶对 mTOR 信号和生长的控制。
Acta Physiol (Oxf). 2009 May;196(1):65-80. doi: 10.1111/j.1748-1716.2009.01972.x. Epub 2009 Feb 19.
7
[mTOR and non-small cell lung cancer].[哺乳动物雷帕霉素靶蛋白与非小细胞肺癌]
Zhongguo Fei Ai Za Zhi. 2010 Jan;13(1):69-72. doi: 10.3779/j.issn.1009-3419.2010.01.13.
8
The potential role of mTOR inhibitors in the treatment of endocrine tumors.mTOR 抑制剂在治疗内分泌肿瘤中的潜在作用。
J Endocrinol Invest. 2010 Apr;33(4):276-81. doi: 10.1007/BF03345792. Epub 2010 May 5.
9
Targeting mTOR globally in cancer: thinking beyond rapamycin.靶向肿瘤 mTOR：超越雷帕霉素的思考。
Cell Cycle. 2009 Dec;8(23):3831-7. doi: 10.4161/cc.8.23.10070. Epub 2009 Dec 14.
10
Rapamycin: the cure for all that ails.雷帕霉素：治愈一切疾病。
J Mol Cell Biol. 2010 Feb;2(1):17-9. doi: 10.1093/jmcb/mjp033. Epub 2009 Oct 4.
引用本文的文献
1
Dose-dependent immunotoxic mechanisms of celastrol via modulation of the PI3K-Akt signaling pathway.雷公藤红素通过调节PI3K-Akt信号通路的剂量依赖性免疫毒性机制。
Front Pharmacol. 2025 May 27;16:1567193. doi: 10.3389/fphar.2025.1567193. eCollection 2025.
2
Identification of biomarkers and potential drug targets in DFU based on fundamental experiments and multi-omics joint analysis.基于基础实验和多组学联合分析鉴定糖尿病足溃疡中的生物标志物和潜在药物靶点。
Front Pharmacol. 2025 May 23;16:1561179. doi: 10.3389/fphar.2025.1561179. eCollection 2025.
3
Protein Kinases as Mediators for miRNA Modulation of Neuropathic Pain.蛋白激酶作为微小RNA调节神经性疼痛的介质
Cells. 2025 Apr 11;14(8):577. doi: 10.3390/cells14080577.
4
Molecular Mechanisms and Therapeutic Strategies to Overcome Resistance to Endocrine Therapy and CDK4/6 Inhibitors in Advanced ER+/HER2- Breast Cancer.晚期ER+/HER2-乳腺癌中克服内分泌治疗和CDK4/6抑制剂耐药的分子机制及治疗策略
Int J Mol Sci. 2025 Apr 7;26(7):3438. doi: 10.3390/ijms26073438.
5
Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment.发育状态、p53状态和干扰素信号传导对胶质母细胞瘤细胞对放疗和替莫唑胺治疗反应的影响。
PLoS One. 2025 Feb 7;20(2):e0315171. doi: 10.1371/journal.pone.0315171. eCollection 2025.
6
JR-AB2-011 induces fast metabolic changes independent of mTOR complex 2 inhibition in human leukemia cells.JR-AB2-011 诱导人白血病细胞快速的代谢变化，而不依赖于 mTOR 复合物 2 的抑制。
Pharmacol Rep. 2024 Dec;76(6):1390-1402. doi: 10.1007/s43440-024-00649-7. Epub 2024 Sep 11.
7
Charting cancer's course: revealing the role of diet, exercise, and the microbiome in cancer evolution and immunotherapy response.绘制癌症进程：揭示饮食、运动和微生物群在癌症演变及免疫治疗反应中的作用
Clin Transl Oncol. 2025 Feb;27(2):473-485. doi: 10.1007/s12094-024-03595-1. Epub 2024 Aug 2.
8
Comprehensive Review on Bimolecular Fluorescence Complementation and Its Application in Deciphering Protein-Protein Interactions in Cell Signaling Pathways.双分子荧光互补及其在破译细胞信号通路中蛋白质-蛋白质相互作用的应用的综合综述。
Biomolecules. 2024 Jul 17;14(7):859. doi: 10.3390/biom14070859.
9
Regulation of mesenchymal stem cell differentiation by autophagy.自噬对间充质干细胞分化的调控
Open Med (Wars). 2024 May 21;19(1):20240968. doi: 10.1515/med-2024-0968. eCollection 2024.
10
A Novel Role for the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Delta Isoform in Hepatocellular Proliferation.磷脂酰肌醇-4,5-二磷酸 3-激酶 δ 同工酶在肝细胞增殖中的新作用。
Am J Pathol. 2024 Aug;194(8):1511-1527. doi: 10.1016/j.ajpath.2024.03.016. Epub 2024 May 3.
本文引用的文献
1
Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1.Rictor磷酸化位点的表征揭示了S6K1对mTOR复合物2的直接调控。
Mol Cell Biol. 2009 Nov;29(21):5657-70. doi: 10.1128/MCB.00735-09. Epub 2009 Aug 31.
2
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.新型雷帕霉素哺乳动物靶点ATP竞争性选择性抑制剂的生化、细胞及体内活性
Cancer Res. 2009 Aug 1;69(15):6232-40. doi: 10.1158/0008-5472.CAN-09-0299. Epub 2009 Jul 7.
3
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.人类癌症中致癌性PIK3CA突变下游的非AKT依赖性信号传导。
Cancer Cell. 2009 Jul 7;16(1):21-32. doi: 10.1016/j.ccr.2009.04.012.
4
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.DEPTOR是一种mTOR抑制剂，在多发性骨髓瘤细胞中经常过度表达，是其生存所必需的。
Cell. 2009 May 29;137(5):873-86. doi: 10.1016/j.cell.2009.03.046. Epub 2009 May 14.
5
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).库-0063794是雷帕霉素哺乳动物靶点（mTOR）的特异性抑制剂。
Biochem J. 2009 Jun 12;421(1):29-42. doi: 10.1042/BJ20090489.
6
The pharmacology of mTOR inhibition.mTOR抑制的药理学
Sci Signal. 2009 Apr 21;2(67):pe24. doi: 10.1126/scisignal.267pe24.
7
Molecular mechanisms of mTOR-mediated translational control.mTOR介导的翻译控制的分子机制。
Nat Rev Mol Cell Biol. 2009 May;10(5):307-18. doi: 10.1038/nrm2672. Epub 2009 Apr 2.
8
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.mTOR的活性位点抑制剂靶向mTORC1和mTORC2的雷帕霉素抗性输出。
PLoS Biol. 2009 Feb 10;7(2):e38. doi: 10.1371/journal.pbio.1000038.
9
PI3K and mTOR inhibitors: a new generation of targeted anticancer agents.PI3K和mTOR抑制剂：新一代靶向抗癌药物。
Curr Opin Cell Biol. 2009 Apr;21(2):194-8. doi: 10.1016/j.ceb.2008.12.011. Epub 2009 Feb 7.
10
mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.mTOR复合物2是小鼠中由Pten缺失诱导的前列腺癌发生所必需的。
Cancer Cell. 2009 Feb 3;15(2):148-59. doi: 10.1016/j.ccr.2008.12.017.
Zotero 插件